Press ReleasesWho We Are / News / Press Releases Goodwin Biotechnology Announces the Return of Two Important Monoclonal Antibody Projects from Alethia Biotherapeutics October 1, 2013 Goodwin Biotechnology Announces the Appointment of SooYoung S. Lee, PhD as Chief Operating Officer September 1, 2013 Goodwin Biotechnology, Inc. Announces Process Development Sub-Contract for an Anthrax Vaccine June 3, 2013 Goodwin Biotechnology and Coldstream Laboratories Announce a Collaboration to Develop and Manufacture Cytotoxic Antibody Drug Conjugates April 25, 2013 Goodwin Biotechnology Inc. Completes Development of AREVA’s New Cancer Treatment December 12, 2012 Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards October 1, 2012 Goodwin Biotechnology and MD Anderson Cancer Center Collaborate on the GMP Manufacturing of a Fusion Protein Conjugate that Potentially Represents a Critical Advance in Oncology June 4, 2012 ImmunoSite Technologies Allies with Goodwin Biotechnology Increasing Capabilities November 1, 2011 Goodwin Biotechnology Announces a Collaboration with Spectros Corporation October 1, 2011 Goodwin Biotechnology and OncoMax, a Maxwell Biotech Portfolio Company, Announce a “Bench-to-Clinic” Collaboration for an Important Advance in Oncology January 1, 2011 Previous 1 2 3 4 5 Next